Shape Biopharmaceuticals GmbH
Shape Biopharmaceuticals specializes in the development of innovative immunotherapies based on nanoparticles. These nanomedicines are designed to help patients with chronic diseases or forms of cancer for which no therapies currently exist. The nanomedicines modulate the immune system to produce antibodies that can fight the disease. Shape combines expertise in immunobiology, chemistry, and medicine with cutting-edge technologies for computer-aided protein design and nanoparticle engineering. Shape has locations in Cambridge, Massachusetts (USA) and the Canton of Zurich, Switzerland.
Shape Biopharmaceuticals GmbH
Riedhofstrasse 11
CH-8804 Au ZH
+41 44 586 27 25
www.shapebiopharma.com
info@shapebiopharma.com
